Rigel Pharmaceuticals Competitors and Similar CompaniesClear all
Rigel Pharmaceuticals's competitors and similar companies include Novartis, Hutchison China Meditech and Ajinomoto Bio-Pharma Services.
 Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products. |  Ajinomoto Bio-Pharma Services Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO). | |
Founding Date | Founding Date 1996 | Founding Date 1996 | Founding Date 2000 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations South San Francisco, US HQ | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more | Locations San Diego, US HQ Wetteren, BE Visakhapatnam, IN Osaka, JP |
Employees | Employees 1633% increase | Employees 75,883 | Employees 1,811 | Employees 68610% decrease |
Valuation ($) | Valuation ($) 256 m | Valuation ($) N/A | Valuation ($) 3.6 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $294.3m (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $548.5m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $19.6m (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $324.4m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $274.7m (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $224.2m (FY, 2025) | Gross profit N/A |
Net income | Net income $367m (FY, 2025) | Net income $14b (FY, 2025) | Net income $435.1m (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 130m | Total funding raised $ 6.5m | Total funding raised $ 100m | Total funding raised $ 3.5m |
For sources of this data, please see the company profile
View Company Profiles
Novartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyHutchison China Meditech
HQ
Shanghai, CN
Employees
1,811
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
View companyAjinomoto Bio-Pharma Services
HQ
San Diego, US
Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO).
View company